Type 2 diabetes DTx pilot in Germany

Clear.bio is a CE-marked prescription digital intervention Type 2 Diabetes, combining real-time CGM data, personalised nutrition insights, and remote dietitian coaching.

In the Netherlands, Clear.bio is reimbursed and widely adopted in primary care, showing strong real-world outcomes:

• Significant HbA1c reduction (~11 mmol/mol in 3 months)

• Improved Time in Range and average glucose

• High patient satisfaction and sustained lifestyle change

For international expansion, Clear.bio is preparing a pilot in the German healthcare system to show feasibility, and (cost)effectiveness. We searching collaborations with physicians who are interested in integrating data-driven lifestyle therapy into diabetes care.